SUPERNUS PHARMACEUTICALS, INC. Earnings Per Share (Basic)
SUPERNUS PHARMACEUTICALS, INC. (SUPN) reported Earnings Per Share (Basic) of -$1.01 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-03
- SUPERNUS PHARMACEUTICALS, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$1.01, a 352.50% decline year-over-year.
- SUPERNUS PHARMACEUTICALS, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.04.
- SUPERNUS PHARMACEUTICALS, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.80, a 214.29% decline year-over-year.
- SUPERNUS PHARMACEUTICALS, INC. earnings per share, basic for the quarter ending 2025-06-30 was $0.40, a 11.11% increase year-over-year.
- SUPERNUS PHARMACEUTICALS, INC. earnings per share, basic for fiscal 2025 was -$0.68, a 150.75% decline from fiscal 2024.
- SUPERNUS PHARMACEUTICALS, INC. earnings per share, basic for fiscal 2024 was $1.34, a 6600.00% increase from fiscal 2023.
- SUPERNUS PHARMACEUTICALS, INC. earnings per share, basic for fiscal 2023 was $0.02, a 98.23% decline from fiscal 2022.
- SUPERNUS PHARMACEUTICALS, INC. earnings per share, basic for fiscal 2022 was $1.13, a 11.88% increase from fiscal 2021.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$1.01 10-Q · filed 2026-08-03 | -$1.05 10-Q · filed 2026-08-03 | ||||||
| 2026-03-31 | -$0.04 10-Q · filed 2026-05-05 | |||||||
| 2025-12-31 | -$0.68 10-K · filed 2026-03-02 | |||||||
| 2025-09-30 | -$0.80 10-Q · filed 2025-11-06 | -$0.61 10-Q · filed 2025-11-06 | ||||||
| 2025-06-30 | $0.40 10-Q · filed 2026-08-03 | $0.19 10-Q · filed 2026-08-03 | ||||||
| 2025-03-31 | -$0.21 10-Q · filed 2026-05-05 | |||||||
| 2024-12-31 | $1.34 10-K · filed 2026-03-02 | |||||||
| 2024-09-30 | $0.70 10-Q · filed 2025-11-06 | $1.06 10-Q · filed 2025-11-06 | ||||||
| 2024-06-30 | $0.36 10-Q · filed 2025-08-05 | $0.37 10-Q · filed 2025-08-05 | $0.39 derived: net income ÷ weighted average shares · filed 2026-03-02 | $0.10 derived: net income ÷ weighted average shares · filed 2026-03-02 | ||||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-06 | $0.02 derived: net income ÷ weighted average shares · filed 2026-03-02 | -$0.27 derived: net income ÷ weighted average shares · filed 2026-03-02 | -$0.28 derived: net income ÷ weighted average shares · filed 2026-03-02 | ||||
| 2023-12-31 | $0.02 derived: net income ÷ weighted average shares · filed 2026-03-02 | -$0.27 derived: net income ÷ weighted average shares · filed 2026-03-02 | -$0.29 derived: net income ÷ weighted average shares · filed 2026-03-02 | $0.02 10-K · filed 2026-03-02 | ||||
| 2023-09-30 | -$0.29 10-Q · filed 2024-11-04 | -$0.31 derived: net income ÷ weighted average shares · filed 2024-11-04 | $0.00 10-Q · filed 2024-11-04 | $0.50 derived: net income ÷ weighted average shares · filed 2025-02-25 | ||||
| 2023-06-30 | -$0.02 10-Q · filed 2024-08-06 | $0.30 10-Q · filed 2024-08-06 | $0.80 derived: net income ÷ weighted average shares · filed 2025-02-25 | $0.83 derived: net income ÷ weighted average shares · filed 2025-02-25 | ||||
| 2023-03-31 | $0.31 10-Q · filed 2024-05-08 | $0.82 derived: net income ÷ weighted average shares · filed 2025-02-25 | $0.85 derived: net income ÷ weighted average shares · filed 2025-02-25 | $1.01 derived: net income ÷ weighted average shares · filed 2025-02-25 | ||||
| 2022-12-31 | $0.49 derived: net income ÷ weighted average shares · filed 2025-02-25 | $0.52 derived: net income ÷ weighted average shares · filed 2025-02-25 | $0.69 derived: net income ÷ weighted average shares · filed 2025-02-25 | $1.13 10-K · filed 2025-02-25 | ||||
| 2022-09-30 | $0.03 10-Q · filed 2023-11-08 | $0.20 derived: net income ÷ weighted average shares · filed 2023-11-08 | $0.66 10-Q · filed 2023-11-08 | $0.74 derived: net income ÷ weighted average shares · filed 2023-11-08 | ||||
| 2022-06-30 | $0.15 10-Q · filed 2023-08-08 | $0.63 10-Q · filed 2023-08-08 | $0.71 derived: net income ÷ weighted average shares · filed 2023-08-08 | $1.11 derived: net income ÷ weighted average shares · filed 2023-08-08 | ||||
| 2022-03-31 | $0.48 10-Q · filed 2023-05-09 | $0.54 derived: net income ÷ weighted average shares · filed 2023-05-09 | $0.95 derived: net income ÷ weighted average shares · filed 2023-05-09 | $1.40 derived: net income ÷ weighted average shares · filed 2023-05-09 | ||||
| 2021-12-31 | $0.05 derived: net income ÷ weighted average shares · filed 2023-03-09 | $0.45 derived: net income ÷ weighted average shares · filed 2023-03-09 | $0.90 derived: net income ÷ weighted average shares · filed 2023-03-09 | $1.01 10-K · filed 2023-03-09 | ||||
| 2021-09-30 | $0.41 10-Q · filed 2022-11-09 | $0.85 derived: net income ÷ weighted average shares · filed 2022-11-09 | $0.96 10-Q · filed 2022-11-09 | $1.54 derived: net income ÷ weighted average shares · filed 2023-03-09 | ||||
| 2021-06-30 | $0.45 10-Q · filed 2022-08-08 | $0.56 10-Q · filed 2022-08-08 | $1.14 derived: net income ÷ weighted average shares · filed 2023-03-09 | $1.90 derived: net income ÷ weighted average shares · filed 2023-03-09 | ||||
| 2021-03-31 | $0.11 10-Q · filed 2022-05-12 | $0.69 derived: net income ÷ weighted average shares · filed 2023-03-09 | $1.45 derived: net income ÷ weighted average shares · filed 2023-03-09 | $2.11 derived: net income ÷ weighted average shares · filed 2023-03-09 | ||||
| 2020-12-31 | $0.58 derived: net income ÷ weighted average shares · filed 2023-03-09 | $1.34 derived: net income ÷ weighted average shares · filed 2023-03-09 | $2.00 derived: net income ÷ weighted average shares · filed 2023-03-09 | $2.41 10-K · filed 2023-03-09 | ||||
| 2020-09-30 | $0.76 10-Q · filed 2021-11-05 | $1.42 derived: net income ÷ weighted average shares · filed 2021-11-05 | $1.83 10-Q · filed 2021-11-05 | |||||
| 2020-06-30 | $0.66 10-Q · filed 2021-08-06 | $1.07 10-Q · filed 2021-08-06 | ||||||
| 2020-03-31 | $0.41 10-Q · filed 2021-05-07 | |||||||
| 2019-12-31 | $0.63 10-K · filed 2020-02-28 | $2.16 10-K · filed 2022-04-13 | ||||||
| 2019-09-30 | $0.55 10-Q · filed 2020-11-06 | $1.53 10-Q · filed 2020-11-06 | ||||||
| 2019-06-30 | $0.62 10-Q · filed 2020-08-17 | $0.98 10-Q · filed 2020-08-17 | ||||||
| 2019-03-31 | $0.35 10-Q · filed 2020-05-15 | |||||||
| 2018-12-31 | $0.50 10-K · filed 2020-02-28 | $1.03 derived: net income ÷ weighted average shares · filed 2021-03-08 | $1.62 derived: net income ÷ weighted average shares · filed 2021-03-08 | $2.13 10-K · filed 2021-03-08 | ||||
| 2018-09-30 | $0.54 10-K · filed 2020-02-28 | $1.13 derived: net income ÷ weighted average shares · filed 2019-11-08 | $1.64 10-Q · filed 2019-11-08 | $1.91 derived: net income ÷ weighted average shares · filed 2020-02-28 | ||||
| 2018-06-30 | $0.59 10-K · filed 2020-02-28 | $1.10 10-Q · filed 2019-08-09 | $1.37 derived: net income ÷ weighted average shares · filed 2020-02-28 | $1.69 derived: net income ÷ weighted average shares · filed 2020-02-28 | ||||
| 2018-03-31 | $0.51 10-K · filed 2020-02-28 | $0.78 derived: net income ÷ weighted average shares · filed 2020-02-28 | $1.09 derived: net income ÷ weighted average shares · filed 2020-02-28 | $1.44 derived: net income ÷ weighted average shares · filed 2020-02-28 | ||||
| 2017-12-31 | $0.27 10-K · filed 2019-03-01 | $0.58 derived: net income ÷ weighted average shares · filed 2020-02-28 | $0.92 derived: net income ÷ weighted average shares · filed 2020-02-28 | $1.13 10-K · filed 2020-02-28 | ||||
| 2017-09-30 | $0.31 10-K · filed 2019-03-01 | $0.66 derived: net income ÷ weighted average shares · filed 2018-11-09 | $0.86 10-Q · filed 2018-11-09 | $1.15 derived: net income ÷ weighted average shares · filed 2019-03-01 | ||||
| 2017-06-30 | $0.34 10-K · filed 2019-03-01 | $0.55 10-Q · filed 2018-08-09 | $0.84 derived: net income ÷ weighted average shares · filed 2019-03-01 | $2.08 derived: net income ÷ weighted average shares · filed 2019-03-01 | ||||
| 2017-03-31 | $0.21 10-K · filed 2019-03-01 | $0.49 derived: net income ÷ weighted average shares · filed 2019-03-01 | $1.74 derived: net income ÷ weighted average shares · filed 2019-03-01 | $1.95 derived: net income ÷ weighted average shares · filed 2019-03-01 | ||||
| 2016-12-31 | $0.29 10-K · filed 2018-03-01 | $1.53 derived: net income ÷ weighted average shares · filed 2019-03-01 | $1.74 derived: net income ÷ weighted average shares · filed 2019-03-01 | $1.84 10-K · filed 2019-03-01 | ||||
| 2016-09-30 | $1.25 10-K · filed 2018-03-01 | $1.46 derived: net income ÷ weighted average shares · filed 2017-11-09 | $1.56 10-Q · filed 2017-11-09 | $1.70 derived: net income ÷ weighted average shares · filed 2018-03-01 | ||||
| 2016-06-30 | $0.21 10-K · filed 2018-03-01 | $0.20 10-Q · filed 2016-08-05 | $0.31 10-Q · filed 2017-08-03 | $0.30 10-Q · filed 2016-08-05 | $0.45 derived: net income ÷ weighted average shares · filed 2018-03-01 | $0.53 derived: net income ÷ weighted average shares · filed 2018-03-01 | ||
| 2016-03-31 | $0.10 10-K · filed 2018-03-01 | $0.24 derived: net income ÷ weighted average shares · filed 2018-03-01 | $0.32 derived: net income ÷ weighted average shares · filed 2018-03-01 | $0.37 derived: net income ÷ weighted average shares · filed 2018-03-01 | ||||
| 2015-12-31 | $0.14 10-K · filed 2017-03-16 | $0.22 derived: net income ÷ weighted average shares · filed 2018-03-01 | $0.27 derived: net income ÷ weighted average shares · filed 2018-03-01 | $0.29 10-K · filed 2018-03-01 | $0.30 10-K · filed 2016-03-09 | |||
| 2015-09-30 | $0.08 10-K · filed 2017-03-16 | $0.09 10-Q · filed 2015-11-09 | $0.13 derived: net income ÷ weighted average shares · filed 2017-01-23 | $0.15 10-Q/A · filed 2017-01-20 | ||||
| 2015-06-30 | $0.05 10-K · filed 2017-03-16 | $0.04 10-Q · filed 2015-08-07 | $0.07 10-Q/A · filed 2017-01-23 | $0.06 10-Q · filed 2015-08-07 | ||||
| 2015-03-31 | $0.02 10-K · filed 2017-03-16 | |||||||
| 2014-12-31 | $0.09 10-K/A · filed 2017-01-20 | $0.10 10-K · filed 2015-03-12 | -$0.26 10-K · filed 2017-03-16 | $0.47 10-K · filed 2015-03-12 | ||||
| 2014-09-30 | -$0.06 10-Q/A · filed 2017-01-20 | $0.65 10-Q · filed 2014-11-12 | -$0.35 10-Q/A · filed 2017-01-20 | $0.37 10-Q · filed 2014-11-12 | ||||
| 2014-06-30 | $0.08 10-K/A · filed 2017-01-20 | -$0.30 10-Q · filed 2015-08-07 | ||||||
| 2014-03-31 | -$0.38 10-K/A · filed 2017-01-20 | |||||||
| 2013-12-31 | -$0.65 10-K · filed 2015-03-12 | -$1.42 derived: net income ÷ weighted average shares · filed 2017-01-20 | -$2.30 derived: net income ÷ weighted average shares · filed 2017-01-20 | -$2.90 10-K/A · filed 2017-01-20 | ||||
| 2013-09-30 | -$0.78 10-K · filed 2015-03-12 | -$1.66 derived: net income ÷ weighted average shares · filed 2014-11-12 | -$2.26 10-Q · filed 2014-11-12 | |||||
| 2013-06-30 | -$0.89 10-K · filed 2015-03-12 | -$1.48 10-Q · filed 2014-08-12 | ||||||
| 2013-03-31 | -$0.60 10-K · filed 2015-03-12 | |||||||
| 2012-12-31 | -$2.72 10-K · filed 2015-03-12 | |||||||
| 2012-06-30 | -$0.61 derived: net income ÷ weighted average shares · filed 2013-08-14 | -$2.21 derived: net income ÷ weighted average shares · filed 2013-08-14 | ||||||
| 2012-03-31 | -$6.05 derived: net income ÷ weighted average shares · filed 2013-05-15 | |||||||
| 2011-12-31 | $31.39 derived: net income ÷ weighted average shares · filed 2014-03-21 | |||||||
| 2011-06-30 | -$5.17 derived: net income ÷ weighted average shares · filed 2012-08-13 | -$12.64 derived: net income ÷ weighted average shares · filed 2012-08-13 | ||||||
| 2011-03-31 | -$7.48 derived: net income ÷ weighted average shares · filed 2012-06-08 | |||||||
| 2010-12-31 | -$26.38 derived: net income ÷ weighted average shares · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |